Daiichi Sankyo To Send More Personnel To Improve Ranbaxy Quality
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo plans to pour more of its personnel into India to help beef up quality control at its Ranbaxy Laboratories unit and get two of its plants back exporting generic drugs to the U.S. sooner than the original 2017 date.